Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

about

Serum lipid and glucose profiles in HIV-positive Nigerian children.

P2860

Q42334793-1DC7F3E4-7CCF-41E6-B8CE-621F67905E38

P2860

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

Item

http://www.wikidata.org/entity/Q40579729

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

@en

type

Item

label

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

@en

prefLabel

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

@en

P1476

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

@en

P2093

Aparna Mukherjee

http://www.w3.org/2001/XMLSchema#string

R Lakshmy

http://www.w3.org/2001/XMLSchema#string

Rakesh Lodha

http://www.w3.org/2001/XMLSchema#string

Sushil K Kabra

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic complications of antiretroviral therapy in children.

Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions.

Dyslipidemia in a cohort of HIV-infected Latin American children receiving highly active antiretroviral therapy.

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration.

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

Extensive implementation of highly active antiretroviral therapy shows great effect on survival and surrogate markers in vertically HIV-infected children.

Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile.

Lipodystrophy and metabolic complications of highly active antiretroviral therapy.

Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children.

Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.

P2888

s12098-015-1859-3

P304

226-231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12098-015-1859-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anirban Mandal

P577

2015-09-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281541300

http://www.w3.org/2001/XMLSchema#string

P698

26334860

http://www.w3.org/2001/XMLSchema#string

P921

dyslipidemias

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

about

P2860

P2860

Dyslipidemia in HIV Infected Children Receiving Highly Active Antiretroviral Therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921